Pure Global
NCT06021041

A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients

Tongji Hospital·ClinicalTrials.govRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Tuberculosis
Study type
Observational
Sponsor & location
Primary sponsor
Tongji Hospital
Location
Wuhan,Hubei, China
Timeline & enrollment
Phase
N/A
Start date
Jan 13, 2018
End date
Feb 01, 2024
Enrollment
900 participants
Primary outcome

2-year survival rate,2-year disability rate

Summary

This is a retrospective clinical study to analyze the clinical characteristics,
 complications, and effects of different treatment options on long-term prognosis of severe
 tuberculosis patients. All cases of severe tuberculosis diagnosed between 2016 and 2021 were
 included in the electronic medical record system of one center, and data such as
 demographics, hospitalization information, clinical information, laboratory or imaging
 examinations, treatment plans, and outcomes were collected.

ICD-10 classifications
TuberculosisLatent tuberculosisTuberculosis of other organsCongenital tuberculosisSequelae of tuberculosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06021041
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06021041 through Pure Global AI's free database. This phase not specified trial is sponsored by Tongji Hospital and is currently Recruitment Completed. The study focuses on Tuberculosis. Target enrollment is 900 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.